Vivmark Residential (VMRK)
Valuation Overview•Is Vivmark Residential Overvalued or Undervalued?
Trading at a discount to intrinsic cash flow value, implying pessimistic long-term market expectations.
Moderate quality score of 56/100, reflecting stable operating margins and manageable leverage.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Confirm your valuation thesis with live pattern overlays, key pivot levels, and AI trade plans.
Verdict: Average quality business weighed down by significant solvency concerns.
Wall Street is broadly bullish, projecting solid upside. This is paired with healthy capital returns, anchored by a strong dividend yield, though free cash flow coverage appears tight.
VMRK demonstrates strong business quality with robust profitability and healthy margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company exhibits steady, low-single-digit revenue growth paired with robust earnings compounding (12.4% EPS 3Y CAGR). This growth is supported by elite operational efficiency, sustaining an impressive 35.7% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | +4.1% | +4.3% | +3.8% | +1.2% | |
| EBITDA | $612.9M | — | -6.0% | — | — | |
| Net Income | -$735.1M | +8.1% | +13.0% | — | +2.6% | |
| EPS (Diluted) | $-1.27 | +7.0% | +12.4% | +5.1% | +2.4% | |
| Free Cash Flow | — | +2.8% | +1.8% | +3.2% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 47.2% | 57.7% | 59.7% | 62.9% |
| Operating Margin | 35.7% | 53.0% | 57.8% | 51.0% |
| Net Margin | -4.2% | 33.3% | 36.5% | 48.1% |
| FCF Margin | — | 41.8% | 42.9% | 43.1% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q3'26Latest | $0.44 | $0.30 | -31.4% | ||
| Q2'26 | $0.28 | $0.24 | -15.5% | ||
| Q1'26 | $1.04 | $1.03 | -1.0% | ||
| Q4'25 | $0.43 | $0.76 | +77.7% | ||
| Q3'25 | $0.34 | $0.51 | +49.8% | ||
| Q2'25 | $0.26 | $0.69 | +165.7% | ||
| Q1'25 | $0.44 | $1.10 | +150.0% | ||
| Q4'24 | $0.41 | $0.38 | -7.7% |
Total return is +16.1% (1Y), outperforming the benchmark by +6.4%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +9.9% | +2.2% | — |
| 1Y | +16.1% | +6.4% | +4.8% |
| 3YCAGR | +10.5% | -8.6% | +15.1% |
| 5YCAGR | -1.5% | -10.9% | +15.7% |
| 10YCAGR | +3.8% | -9.3% | — |
The S&P 500 is at 29.9x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Vivmark Residential (VMRK) valuation, health, and returns.
Vivmark Residential is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Fair versus peers compared to industry peers. undervalued (implying +63.2% upside to DCF intrinsic value of $106.68)
Vivmark Residential has multiple valuation anchors: DCF Intrinsic Value: $106.68 | Peer Relative Fair Value: $65.97 | Wall Street Analyst Target: $72.63 (implying +11.1% upside). A convergence of these signals offers higher conviction.
Vivmark Residential displays fair financial health with a composite quality score of 56/100, supported by a Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 4.2%.
Vivmark Residential pays a 4.1% dividend yield, covered by a 93% payout ratio with 4 years of growth, supplemented by a 0.6% buyback yield.
Vivmark Residential's current growth trajectory is Stable. The company achieved +4.1% 1Y revenue growth and +7.0% 1Y EPS growth, compared to its 3Y revenue CAGR of +4.3%.
Wall Street consensus is Hold based on 46 analysts, beating EPS expectations in 58% of recent quarters with a -3-quarter streak. The consensus price target represents a +11.1% change from current levels.
Investment risks for Vivmark Residential include: -11.6% 1-year max drawdown, stretched payout ratio. Volatility risk is characterized by a beta of 0.14x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.